» Articles » PMID: 32948895

Assessment of Side Effects After Serial Intralesional Steroid Injections for Idiopathic Subglottic Stenosis

Overview
Date 2020 Sep 19
PMID 32948895
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To assess the incidence and severity of 12 systemic side effects of serial intralesional steroid injections (SILSI) in patients with idiopathic subglottic stenosis (iSGS).

Methods: This retrospective study included patients with iSGS who underwent SILSI with Triamcinolone 40 mg/dL. After SILSI, the patients were asked to answer 12 questions regarding frequently encountered systemic side effects of steroids. Each answer was rated as mild, moderate, or severe. Descriptive statistics were used to analyze and present the findings.

Results: The study included 49 patients (42 female and 7 male) with a mean age of 59.1 years (range 21-83 years). Post-SILSI treatment, 27 (55%) reported experiencing side effects while 22 (45%) patients reported no side effects. The most frequent side effect reported in women of reproductive age (n: 8) was menstrual irregularities (3/8, 37%). Other frequently reported side effects were feeling joyful and sleeping difficulties, each reported by 30% of the patients. All side effects resolved after the completion of SILSI.

Conclusions: SILSI can be administered with minimal tolerable side effects. Clinicians should make their patients aware of the most frequent side effects. Special attention should be given to women of reproductive age to inform them of the possibility of menstrual irregularities during SILSI.

Citing Articles

Local adjuncts to minimally invasive endoscopic interventions for benign laryngotracheal stenosis: a meta-analysis.

Ming W, Zuo J, Han J, Chen J Eur Arch Otorhinolaryngol. 2024; 281(10):5395-5410.

PMID: 38967672 DOI: 10.1007/s00405-024-08810-x.


Case report: Idiopathic subglottic stenosis in a girl; successful treatment with macrolides.

Tebbe W, Wittkowski H, Tebbe J, Hulskamp G Front Pediatr. 2022; 10:888282.

PMID: 36061399 PMC: 9434006. DOI: 10.3389/fped.2022.888282.


An Updated Review of Subglottic Stenosis: Etiology, Evaluation, and Management.

Pasick L, Anis M, Rosow D Curr Pulmonol Rep. 2022; 11(2):29-38.

PMID: 35261874 PMC: 8892813. DOI: 10.1007/s13665-022-00286-6.


Serial Intralesional Steroid Injection for Subglottic Stenosis: Systemic Side Effects and Impact on Surgery-Free Interval.

Neevel A, Schuman A, Morrison R, Hogikyan N, Kupfer R OTO Open. 2021; 5(4):2473974X211054842.

PMID: 34734156 PMC: 8558814. DOI: 10.1177/2473974X211054842.

References
1.
Hseu A, Benninger M, Haffey T, Lorenz R . Subglottic stenosis: a ten-year review of treatment outcomes. Laryngoscope. 2013; 124(3):736-41. DOI: 10.1002/lary.24410. View

2.
Carpenter P, Pierce J, Smith M . Outcomes after cricotracheal resection for idiopathic subglottic stenosis. Laryngoscope. 2018; 128(10):2268-2272. DOI: 10.1002/lary.27263. View

3.
Gouveris H, Karaiskaki N, Koutsimpelas D, Chongolwatana C, Mann W . Treatment for adult idiopathic and Wegener-associated subglottic stenosis. Eur Arch Otorhinolaryngol. 2012; 270(3):989-93. DOI: 10.1007/s00405-012-2240-z. View

4.
Morrison R, Katsantonis N, Motz K, Hillel A, Garrett C, Netterville J . Pathologic Fibroblasts in Idiopathic Subglottic Stenosis Amplify Local Inflammatory Signals. Otolaryngol Head Neck Surg. 2018; 160(1):107-115. PMC: 6389372. DOI: 10.1177/0194599818803584. View

5.
Franco Jr R, Husain I, Reder L, Paddle P . Awake serial intralesional steroid injections without surgery as a novel targeted treatment for idiopathic subglottic stenosis. Laryngoscope. 2017; 128(3):610-617. DOI: 10.1002/lary.26874. View